Company Profile

Dahlia Biosciences Inc
Profile last edited on: 2/3/22      CAGE: 7ZJ27      UEI: LMAJJM9962F5

Business Identifier: RNA analysis tools enabling precision medicine research with CRISPR cell and tissue reagents
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

953 Indiana Street
San Francisco, CA 94107
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

Specializing in the fields of biotechnology, DNA analysis and diagnostics Dahlia Biosciences is tructured around RNA analysis tools designed to enable precision medicine research with CRISPR cell and tissue reagents. The company's reagent products are to be used to support research, drug development, and clinical diagnostic applications - to empower scientists to study and isolate cells at high resolution via sensitive, robust, and multiplexed RNA detection in both fixed and live cells.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $299,978
Project Title: Multiplexed CRISPR-based immune cell RNA profiling by flow and mass cytometry
2020 1 NIH $299,128
Project Title: Sorting Live Cells Using Rna-Targeting Crispr-Cas9 (Rcas9)

Key People / Management

  Un Kwon-Casado -- Co-Founder & CEO

  Michael Lin -- Co-Founder

  Mitchell O'Connell -- Scientific Advisor

  Sam Sternberg -- Co-Founder & Scientific Advisor

Company News

There are no news available.